The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study

Crit Care. 2020 Dec 7;24(1):677. doi: 10.1186/s13054-020-03406-3.

Matilde Tejlbo Frost¹, Espen Jimenez-Solem^{1

2

3}, Mikkel Zöllner Ankarfeldt^{3

4}, Martin Erik Nyeland¹, Anne Helms Andreasen⁴, Tonny Studsgaard Petersen^{5

6}

¹ Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, indgang 20 C, 2. sal, 2400, Copenhagen, NV, Denmark.
² Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
³ Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
⁴ Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
⁵ Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, indgang 20 C, 2. sal, 2400, Copenhagen, NV, Denmark. tonny.studsgaard.petersen@regionh.dk.
⁶ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. tonny.studsgaard.petersen@regionh.dk.

No abstract available

Publication types